View of RIVAROXABAN AS THE MAIN COMPONENT OF THE TREATMENT OF PATIENTS WITH OBLITERATING ATHEROSCLEROSIS OF THE LOWER EXTREMITIES

Return to Article Details RIVAROXABAN AS THE MAIN COMPONENT OF THE TREATMENT OF PATIENTS WITH OBLITERATING ATHEROSCLEROSIS OF THE LOWER EXTREMITIES Download Download PDF